AngioDynamics | ANGO - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 143.94M 3.22M 2026-06
Boston Scientific USD 4.2B 49M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
ICU Medical USD 491.25M 8.59M 2026-06
Inogen USD 49.14M 665K 2024-09
J&J USD 17.83B 388M 2026-06
Medtronic USD 7.92B 203M 2026-06
Merit Medical Systems USD 358.44M 20.72M 2026-06
Mesa Laboratories USD 33.98M 2.03M 2024-12
Orthofix International USD 213.79M 12.36M 2025-12
Smiths GBP 749M 617M 2026-06
Tandem Diabetes Care USD 268.35M 3.7M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Terumo JPY 222.33B 46.54B 2026-06
Trinity Biotech USD 12.38M 2.44M 2025-12